Pegylated Liposome Simoctocog Alfa

N/A

Report date: 2024/11/23 20:00:08

Base Information

Drug NamePegylated Liposome Simoctocog Alfa
Drug Alias NamePEGylated liposome simoctocog alfaPEGLip
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant coagulation factor
Mechanisms of ActionCoagulation factor VIII replacements
TargetsCoagulation factor X
Therapy Area/IndicationsHemophilia A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryRussian Federation
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAscension Healthcare Development Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAscension Healthcare Development Ltd
Active IndicationsN/A
Inactive IndicationsHemophilia A

Other Information

ATC CodeN/A
Related LinksN/A